Regeneron, Sanofi win Dupixent label expansion for allergic fungal rhinosinusitis
at seekingalpha.com (Tue, 24-Feb 10:32 AM)
Canaccord Genuity Remains a Buy on Regeneron (REGN)
at www.tipranks.com (Mon, 23-Feb 8:46 AM)
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
at www.tipranks.com (Thu, 19-Feb 2:18 PM)
Regeneron granted FDA priority review for rare bone disorder therapy
at seekingalpha.com (Thu, 19-Feb 7:31 AM)
Citi Reaffirms Their Buy Rating on Regeneron (REGN)
at www.tipranks.com (Thu, 19-Feb 2:56 AM)
Dupixent and EYLEA HD Drive Regeneron's Growth Amid Pipeline Advances and Strategic Investments
Market Chameleon (Fri, 30-Jan 8:49 AM)
